Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion.
Most people living with HIV-1 experience rapid viral rebound once antiretroviral therapy is interrupted; however, a small fraction remain in viral remission for an extended duration. Understanding the factors that determine whether viral rebound is likely after treatment interruption can enable the...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-07-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://doi.org/10.1371/journal.ppat.1012236 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850114152579727360 |
|---|---|
| author | Tin Phan Jessica M Conway Nicole Pagane Jasmine Kreig Narmada Sambaturu Sarafa Iyaniwura Jonathan Z Li Ruy M Ribeiro Ruian Ke Alan S Perelson |
| author_facet | Tin Phan Jessica M Conway Nicole Pagane Jasmine Kreig Narmada Sambaturu Sarafa Iyaniwura Jonathan Z Li Ruy M Ribeiro Ruian Ke Alan S Perelson |
| author_sort | Tin Phan |
| collection | DOAJ |
| description | Most people living with HIV-1 experience rapid viral rebound once antiretroviral therapy is interrupted; however, a small fraction remain in viral remission for an extended duration. Understanding the factors that determine whether viral rebound is likely after treatment interruption can enable the development of optimal treatment regimens and therapeutic interventions to potentially achieve a functional cure for HIV-1. We built upon the theoretical framework proposed by Conway and Perelson to construct dynamic models of virus-immune interactions to study factors that influence viral rebound dynamics. We evaluated these models using viral load data from 24 individuals following antiretroviral therapy interruption. The best-performing model accurately captures the heterogeneity of viral dynamics and highlights the importance of the effector cell expansion rate. Our results show that post-treatment controllers and non-controllers can be distinguished based on the effector cell expansion rate in our models. Furthermore, these results demonstrate the potential of using dynamic models incorporating an effector cell response to understand early viral rebound dynamics post-antiretroviral therapy interruption. |
| format | Article |
| id | doaj-art-ee7540f80b7145a281330191c24f0532 |
| institution | OA Journals |
| issn | 1553-7366 1553-7374 |
| language | English |
| publishDate | 2024-07-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Pathogens |
| spelling | doaj-art-ee7540f80b7145a281330191c24f05322025-08-20T02:36:58ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742024-07-01207e101223610.1371/journal.ppat.1012236Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion.Tin PhanJessica M ConwayNicole PaganeJasmine KreigNarmada SambaturuSarafa IyaniwuraJonathan Z LiRuy M RibeiroRuian KeAlan S PerelsonMost people living with HIV-1 experience rapid viral rebound once antiretroviral therapy is interrupted; however, a small fraction remain in viral remission for an extended duration. Understanding the factors that determine whether viral rebound is likely after treatment interruption can enable the development of optimal treatment regimens and therapeutic interventions to potentially achieve a functional cure for HIV-1. We built upon the theoretical framework proposed by Conway and Perelson to construct dynamic models of virus-immune interactions to study factors that influence viral rebound dynamics. We evaluated these models using viral load data from 24 individuals following antiretroviral therapy interruption. The best-performing model accurately captures the heterogeneity of viral dynamics and highlights the importance of the effector cell expansion rate. Our results show that post-treatment controllers and non-controllers can be distinguished based on the effector cell expansion rate in our models. Furthermore, these results demonstrate the potential of using dynamic models incorporating an effector cell response to understand early viral rebound dynamics post-antiretroviral therapy interruption.https://doi.org/10.1371/journal.ppat.1012236 |
| spellingShingle | Tin Phan Jessica M Conway Nicole Pagane Jasmine Kreig Narmada Sambaturu Sarafa Iyaniwura Jonathan Z Li Ruy M Ribeiro Ruian Ke Alan S Perelson Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion. PLoS Pathogens |
| title | Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion. |
| title_full | Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion. |
| title_fullStr | Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion. |
| title_full_unstemmed | Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion. |
| title_short | Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion. |
| title_sort | understanding early hiv 1 rebound dynamics following antiretroviral therapy interruption the importance of effector cell expansion |
| url | https://doi.org/10.1371/journal.ppat.1012236 |
| work_keys_str_mv | AT tinphan understandingearlyhiv1rebounddynamicsfollowingantiretroviraltherapyinterruptiontheimportanceofeffectorcellexpansion AT jessicamconway understandingearlyhiv1rebounddynamicsfollowingantiretroviraltherapyinterruptiontheimportanceofeffectorcellexpansion AT nicolepagane understandingearlyhiv1rebounddynamicsfollowingantiretroviraltherapyinterruptiontheimportanceofeffectorcellexpansion AT jasminekreig understandingearlyhiv1rebounddynamicsfollowingantiretroviraltherapyinterruptiontheimportanceofeffectorcellexpansion AT narmadasambaturu understandingearlyhiv1rebounddynamicsfollowingantiretroviraltherapyinterruptiontheimportanceofeffectorcellexpansion AT sarafaiyaniwura understandingearlyhiv1rebounddynamicsfollowingantiretroviraltherapyinterruptiontheimportanceofeffectorcellexpansion AT jonathanzli understandingearlyhiv1rebounddynamicsfollowingantiretroviraltherapyinterruptiontheimportanceofeffectorcellexpansion AT ruymribeiro understandingearlyhiv1rebounddynamicsfollowingantiretroviraltherapyinterruptiontheimportanceofeffectorcellexpansion AT ruianke understandingearlyhiv1rebounddynamicsfollowingantiretroviraltherapyinterruptiontheimportanceofeffectorcellexpansion AT alansperelson understandingearlyhiv1rebounddynamicsfollowingantiretroviraltherapyinterruptiontheimportanceofeffectorcellexpansion |